Oncogenes and Tumor Growth Factors in Breast Cancer: A minireview

References

• Willet W. The search for the causes of breast and colon cancer. Nature 1989; 338: 389–94
   PubMed Web of Science ®Google Scholar
• Huang H-JS., Yee J-K., Shew J-H., et al. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 1988; 242: 1563–6
   PubMed Web of Science ®Google Scholar
• Nordenskjöld M. Recessive mutations in the oncogenesis of certain solid tumors. Cellular oncogene activation, G Klein, New York, Basel, (in press.)
   Google Scholar
• Nusse R. The int genes in mammary tumorigenesis and in normal development. Trends Genet 1988; 4: 291–5
   PubMed Web of Science ®Google Scholar
• Ali I U, Merlo G, Callahan R, Liderau R. The amplification unit of chromosome 11q13 in aggressive primary breast tumors entail the bcl-1, int-2 and host loci. Oncogene 1989; 4: 89–92
   PubMed Web of Science ®Google Scholar
• Dandekar S, Sukumar S, Zarbl H, Young L JT, Cardiff R D. Specific activation of th cellular Harvey-ras oncogenes in dimethylbenzanthracene-induced mouse mammary tumours. Mol Cell Biol 1986; 6: 4104–8
   PubMed Web of Science ®Google Scholar
• Zarbi H, Sukumar S, Arthur A V, Martin-Zanca D, Barbacid M. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methyl urea during initiation of mammary carcinogenesis in rats. Nature 1985; 315: 382–5
   Google Scholar
• Graham K A, Richardson C L, Minden M D, Trent J M, Buick R N. Varying degrees of amplification of the N-ras oncogene in the human breast cancer cells MCF-7. Cancer Res 1985; 45: 2201–5
   Google Scholar
• Lehväslaiho H, Lehtola L, Sistonen L, Alitalo K. A chimeric EGF-R-neu and protooncogene allows EGF to regulate neu tyrosine kinase and cell transformation. EMBO J 1989; 8: 159–66
   PubMedGoogle Scholar
• Seshadari R, Mathews C, Dobrovic A, Horsfall D J. The significance of oncogene amplification in primary breast cancer. Int J Cancer 1989; 43: 270–2
   Google Scholar
• Slamon D J, Clark G M, Wong S, Levin W J, Ullrich A, McGuire W L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177–82
   PubMed Web of Science ®Google Scholar
• Borg ÅLinell F, Idvall I, et al. HER-2/neu amplification and comedotype breast cancer. Lancet 1989; 1: 1268–9
   Google Scholar
• Varley J M, Swallow J E, Brammar W J, Whittaker J L, Walker R A. Alterations to either c-erbB-s (neu) or c-myc protooncogenes in breast carcinoma correlate with poor short term prognosis. Oncogene 1987; 1: 423–30
   PubMed Web of Science ®Google Scholar
• Escot C, Theillet C, Liderau R, et al. Genetic alteration of the c-myc protooncogenes (MYC) in human primary breast carcinomas. Proc Natl Acad Sci USA 1986; 83: 4834–38
   PubMed Web of Science ®Google Scholar
• Stewart T A, Pattengale P K, Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 1984; 38: 627–37
   PubMed Web of Science ®Google Scholar
• Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P. Coexpression of MMTV/v-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 1987; 49: 465–75
   PubMed Web of Science ®Google Scholar
• Lavialle C, Modjtahedi N, Cassingena R, Brison O. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-5. Oncogene 1988; 3: 335–9
   PubMedGoogle Scholar
• Liu E, Santos G, Lee W MF, Osborne K, Benz C C. Effects of c-myc overexpression on the growth characteristics of MCF-7 human breast cancer cells 1989; 4: 979–84
   Google Scholar
• Morris D W, Cardiff R D. Multistep model of mouse mammary tumor development. Adv Viral Oncol 1987; 7: 123–40
   Google Scholar
• Andres A C, Schönenberger C A, Groner B, Hennighausen L, LeMeur M, Gerlinger P. Ha-ras oncogene expression directed by a milkprotein promoter: Tissue specificity, hormonal regulation, and tumor induction in transgenic mice. Proc Natl Acad Sci 1987; 84: 1299–303
   PubMed Web of Science ®Google Scholar
• Schönenberger C A, Andres A C, Groner B, van der Valk M, LeMeur M, Gerlinger P. Targeted c-myc gene expression in mammary gland of transgenic mice induces mammary tumors with constitutive milk protein transcription. EMBO J 1988; 7: 169–75
   Google Scholar
• Tsukamoto A S, Grosschedt R, Guzman R C, Parslow T, Varmus H E. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adeno-carcinoma in male and female mice. Cell 1988; 55: 619–25
   PubMed Web of Science ®Google Scholar
• Muller W J, Sinn E, Pattengelae P K, Wallace R, Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988; 54: 105–15
   PubMed Web of Science ®Google Scholar
• Lee EY-HP., To H, Shew J-Y., Bookstein R, Scully P, Lee W-H. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 1988; 241: 218–21
   PubMed Web of Science ®Google Scholar
• T'Ang A, Varley J M, Chakraborty S, Murphree A L, Fung Y-KT. Structural rearrangement of the retinooblastoma gene in human breast carcinoma. Science 1988; 242: 263–6
   PubMed Web of Science ®Google Scholar